DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,427,000 | +23.9% | 117,800 | +21.6% | 3.80% | +54.2% |
Q2 2022 | $24,561,000 | -14.1% | 96,880 | -0.6% | 2.47% | +29.4% |
Q1 2022 | $28,597,000 | -42.3% | 97,490 | -35.3% | 1.91% | -29.2% |
Q4 2021 | $49,546,000 | -52.0% | 150,590 | -60.9% | 2.70% | -34.7% |
Q2 2021 | $103,297,000 | -14.3% | 384,920 | -28.1% | 4.13% | -3.2% |
Q1 2021 | $120,569,000 | +287.2% | 535,670 | +270.4% | 4.27% | +242.4% |
Q3 2020 | $31,137,000 | -53.3% | 144,600 | -61.6% | 1.25% | -55.3% |
Q2 2020 | $66,606,000 | +31.9% | 376,665 | +14.5% | 2.79% | +54.9% |
Q4 2019 | $50,490,000 | -49.1% | 328,970 | -52.1% | 1.80% | -52.0% |
Q3 2019 | $99,221,000 | +36.7% | 686,980 | +35.3% | 3.75% | +33.2% |
Q2 2019 | $72,580,000 | -47.7% | 507,840 | -51.7% | 2.82% | -49.8% |
Q1 2019 | $138,716,000 | -10.5% | 1,050,720 | -30.1% | 5.60% | +15.6% |
Q4 2018 | $155,067,000 | +416.7% | 1,503,750 | +444.4% | 4.85% | +387.1% |
Q3 2018 | $30,012,000 | -40.2% | 276,200 | -45.7% | 1.00% | -37.5% |
Q2 2018 | $50,162,000 | -9.8% | 508,330 | -10.5% | 1.59% | -15.8% |
Q1 2018 | $55,609,000 | +380.6% | 567,960 | +355.6% | 1.89% | +401.6% |
Q4 2017 | $11,571,000 | -89.2% | 124,660 | -90.0% | 0.38% | -89.5% |
Q3 2017 | $107,393,000 | -9.3% | 1,251,960 | -10.7% | 3.60% | -15.7% |
Q2 2017 | $118,343,000 | +1070.8% | 1,402,340 | +1086.6% | 4.27% | +820.5% |
Q1 2017 | $10,108,000 | -87.1% | 118,180 | -88.2% | 0.46% | -89.5% |
Q4 2016 | $78,202,000 | +52.3% | 1,004,650 | +67.4% | 4.42% | +70.9% |
Q2 2015 | $51,354,000 | +3.4% | 600,000 | +2.5% | 2.59% | +9.1% |
Q1 2015 | $49,675,000 | +28.1% | 585,100 | +29.3% | 2.37% | +9.6% |
Q4 2014 | $38,784,000 | -43.3% | 452,500 | -49.7% | 2.16% | -38.4% |
Q3 2014 | $68,382,000 | +32.5% | 900,000 | +37.3% | 3.51% | +35.7% |
Q2 2014 | $51,600,000 | – | 655,400 | – | 2.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |